article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

FDI experts at Investment Monitor have highlighted the following list of factors as most important to life sciences companies considering a greenfield investment in 2022: labour, education, industry clusters, domestic market, infrastructure, business environment, costs and quality of life. appeared first on Pharmaceutical Technology.

article thumbnail

Bob Harrell

Pharma Marketing Network

Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). The post Bob Harrell appeared first on Pharma Marketing Network.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Vaccine producers promise equal access in future pandemics

European Pharmaceutical Review

Three trade bodies representing vaccine creators and manufacturers are endorsing The Berlin Declaration framework , a proposal that outlines how the industry would reserve an allocation of real-time vaccine production for swift distribution to priority populations in lower-income countries in future pandemics.

article thumbnail

Strategies for Combination Therapy in Oncology: Part One – Business as Usual

PM360

Combination Therapy in Oncology Combination therapies comprising two or more therapeutic agents have become a cornerstone of oncology management and are increasingly a development focus for the pharmaceutical industry. JAMA Network Open 5 , no. 3 (2022): e222265. Between May 1, 2016, and May 31, 2021, 42% of all U.S. 2022.2265.

article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year. What are the top three supply-related challenges facing pharmaceutical manufacturers?

article thumbnail

The Pandemic Treaty and the opportunity to end ‘vaccine apartheid’

pharmaphorum

Achium outlined that, as of June 2022, over 72% of people in high-income countries had been vaccinated with at least one dose of a COVID-19 vaccine, while only 17% of people in low-income countries could say the same.

article thumbnail

New IFPMA and EFPIA guidance on use of social media by the pharmaceutical industry

pharmaphorum

Digital channels are defined as “ platforms for electronic communication through transmission of digital content over the internet or computer networks. It identifies the most used social media and digital channels and sets out specific guidance for each. Digital Channels include, but are not limited to, social media ”.

Media 89